Italy Synthetic Biology Market Size & Outlook, 2023-2030
Italy synthetic biology market, 2018-2030 (US$M)
Related Markets
Italy synthetic biology market highlights
- The Italy synthetic biology market generated a revenue of USD 793.3 million in 2023 and is expected to reach USD 3,735.8 million by 2030.
- The Italy market is expected to grow at a CAGR of 24.8% from 2024 to 2030.
- In terms of segment, pcr technology was the largest revenue generating technology in 2023.
- NGS Technology is the most lucrative technology segment registering the fastest growth during the forecast period.
Synthetic biology market data book summary
| Market revenue in 2023 | USD 793.3 million |
| Market revenue in 2030 | USD 3,735.8 million |
| Growth rate | 24.8% (CAGR from 2023 to 2030) |
| Largest segment | Pcr technology |
| Fastest growing segment | NGS Technology |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies |
| Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Italy accounted for 5.6% of the global synthetic biology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany synthetic biology market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 3,735.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Synthetic Biology Market Scope
Synthetic Biology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy synthetic biology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.
Pcr technology was the largest segment with a revenue share of 27.51% in 2023. Horizon Databook has segmented the Italy synthetic biology market based on ngs technology, pcr technology, genome editing technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Supportive policies and innovation to reduce the cost of biofuel in Italy are expected to increase advanced biofuel consumption. To meet the demand for biofuel, several companies are undertaking various strategic initiatives for market expansion.
For instance, in July 2021, Eni has signed an agreement with BASF on a joint R&D initiative to reduce CO2 emission. This partnership intends to develop a novel technology to produce advanced bio-propanol from glycerin.
This technology converted glycerin to propanol through the process of catalytic hydro treatment. This biofuel has the potential to decrease 65% to 75% greenhouse gas emissions as compared to fossil fuels. Furthermore, several companies are introducing innovative products, which is expected to fuel growth of synthetic biology market in Italy.
Reasons to subscribe to Italy synthetic biology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy synthetic biology market databook
-
Our clientele includes a mix of synthetic biology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy synthetic biology market , including forecasts for subscribers. This country databook contains high-level insights into Italy synthetic biology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy synthetic biology market size, by technology, 2018-2030 (US$M)
Italy Synthetic Biology Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
